메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

케리, 2026년 보충제 맛 차트 발표: 보충제 및 스포츠 영양의 다음 시대 규정

싱가포르 2026년 1월 17일 -- 맛과 영양 분야의 글로벌 리더인 케리(Kerry)가 아시아 태평양 및 중동 지역을 대상으로 한 2026년 영양 보충제 맛 차트(2026 Supplements Taste Charts)를 발표했다. 이 차트는 해당 지역에서 진화하는 맛 선호도를 강조하고 풍미를 중시하며 라이프스타일이 주도하는 보충제와 스포츠 영양 제품의 부상을 조명했다. 아시아 태평양, 중동 및 아프리카(APMEA) 전역에서 보충제는 일시적인 건강 지원 수단이 아닌 일상적인 웰빙의 일부로 인식되는 경향이 커지고 있다. 소비자들은 수면, 면역력, 소화, 스트레스 관리, 에너지 및 정서적 균형과 같은 혜택에 집중하고 있으며, 이제 맛과 식감이 지속적인 구매와 장기 복용에 강력한 영향을 미치고 있다. 글로벌 보충제 시장은 2029년까지 미화 1070억 달러 규모에 달할 것으로 예상되며, APMEA 지역은 계속해서 강한 성장세를 보이고 있다. 중국, 인도, 동남아시아 및 중동 지역은 높아지는 건강 의식, 바쁜 라이프스타일, 그리고 개인 맞춤형 영양에 대한 관심이 증가함에 따라 시장 성장을 주도하고 있다.&nbs
- 김갑성 기자
- 2026-01-17 09:42
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Biopsy of the Prostate Avoidance Stratification Study), a Phase 3 trial to evaluate the use of Telix's commercial PSMA-PET[1] imaging agents, Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection) and Gozellix® (kit for the preparation of gallium Ga 68 gozetotide injection) in the initial prostate cancer diagnosis setting. The dose was ad
- 김갑성 기자
- 2026-01-17 03:21
POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies

GUANGZHOU, China, Jan. 16, 2026 -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced significant progress in its strategic collaboration with leading domestic pharmaceutical companies to accelerate the growth of its internet hospital business. The Company expects these partnerships to become a core component of its long-term strategy to expand online hospital operations and enhance overall profitability. Against the backdrop of China's accelerating population agin
- 김갑성 기자
- 2026-01-16 22:00
NUH INAUGURATES NEW CENTRE TO ADVANCE PREDICTIVE AND ACCESSIBLE CARE FOR DIGESTIVE HEALTH

The National University Centre for Digestive Health heralds a new era of care through quicker cross-referrals to surgical specialties, strengthened community partnerships and patient-friendly treatment delivery SINGAPORE, Jan. 16, 2026 -- Digestive health is central to overall well-being, influencing nutrition, immunity, and quality of life. Yet common conditions, such as ulcers, liver disease, and colorectal disorders, often go undetected until they lead to serious complications. To address this, the National University Hospital (NUH) has officially opened the National Univers
- 김갑성 기자
- 2026-01-16 22:00
Henlius Showcases "Globalisation 2.0" Strategy and Mid-to-Long-Term Innovation Blueprint at JPM 2026

SAN FRANCISCO, Jan. 16, 2026 -- The 44th J.P.Morgan Healthcare Conference (JPMHC) was successfully held in San Francisco, the United States, from January 12 to 15. As one of the most influential annual events in the global healthcare sector, JPM serves as a key platform for the capital markets and industry leaders to observe emerging trends in pharmaceutical innovation and industry development. The conference attracted more than 8000 global industry leaders, innovators, entrepreneurs, and investors. On January 15 (PST), Dr. Jason Zhu, Executive Director and Chief Executive Officer of Shanghai
- 김갑성 기자
- 2026-01-16 21:00
Taiwan-U.S. Innovation Link Strengthened: Startup Island TAIWAN Partners with the City of Phoenix to Deepen Cross-Border Collaboration in AI, Semiconductors, and Health Tech Startups

TAIPEI, Jan. 16, 2026 -- To accelerate the co-development of Taiwan–U.S. startup ecosystems in artificial intelligence (AI), semiconductors, and advanced technologies, Startup Island TAIWAN, the national startup brand guided by Taiwan's National Development Council (NDC), today announced the signing of a Memorandum of Understanding (MOU) with the City of Phoenix, the Greater Phoenix Economic Council (GPEC), and Tesoro Venture Capital, in collaboration with the Industrial Technology Research Institute (ITRI). Building on TSMC's expansion in Phoenix, the partnership aims to integrate Tai
- 김갑성 기자
- 2026-01-16 14:44
Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market

[ 메디채널 김갑성 기자 ] Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansion Builds an integrated global commercialization platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide Delivers Zylox-Tonbridge's manufacturing and operational synergies across Germany and China Fully unlocks Zylox-Tonbridge's high-efficiency R&D capabilities HANGZHOU, China and BERLIN, Jan. 16, 2026 -- Zylox-Tonbridge (HKEX:2190), a Hong Kong-listed medical technology company focused on neuro-and peripheral vascular interv
- 김갑성 기자
- 2026-01-16 13:00
Kerry Launches 2026 Supplements Taste Charts: Defining the Next Era of Flavour in Supplements and Sports Nutrition

SINGAPORE, Jan. 16, 2026 -- Kerry, a global leader in taste and nutrition, has released its 2026 Supplements Taste Charts for Asia Pacific and the Middle East, highlighting the region's evolving taste preferences and the rise of flavour‑forward, lifestyle‑led supplements and sports nutrition. Across Asia Pacific, Middle East & Africa (APMEA), supplements are increasingly viewed as part of daily wellbeing rather than an occasional health support. Consumers are focused on benefits such as sleep, immunity, digestion, stress management, energy and emotional balance, wit
- 김갑성 기자
- 2026-01-16 12:51
The AKG and Ca-AKG of Xin Tianhe have passed the US Self-GRAS certification

SHENZHEN, China, Jan. 16, 2026 -- On January 7, 2026, the AKG and Ca-AKG of Xin Tianhe Biotechnology successfully completed the Self-GRAS scientific evaluation in accordance with the US FDA GRAS standards and were approved and became the first domestic fermentation products that obtain the GRAS authoritative certification, and obtained the qualification for entering the US market, marking a crucial step to enter the global nutrition and health market. Core Breakthrough: The First Domestic Certification of Fermentation Method is Officially Implemented The alpha-ketoglutaric acid
- 김갑성 기자
- 2026-01-16 12:23
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs

SHANGHAI and HONG KONG, Jan. 16, 2026 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that it recently presented at the 44th Annual J.P. Morgan Healthcare Conference held in San Francisco. At the conference, Antengene shared the latest data and clinical development plans for its core clinical asset, ATG-022 (a CLDN18
- 김갑성 기자
- 2026-01-16 09:00

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-01-17_SAT

2026-01-16_FRI

POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies 22:00

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 17일 17시 20분